Conference Coverage

Urinary Dysfunction Stands Out on Retigabine's Safety Profile

Publish date: December 20, 2011

 

FROM THE ANNUAL MEETING OF THE AMERICAN EPILEPSY SOCIETY

The study was funded by GSK and Valeant Pharmaceuticals International, and all of the investigators are employees of either company.

Pages

Recommended Reading

Implanted EEG Device Predicts Seizures in Early Study
MDedge Psychiatry
Chronic Headache Persists in Children With Head Injury
MDedge Psychiatry
Progesterone Quells Some Intractable Catamenial Seizures
MDedge Psychiatry
Study Provides More Evidence of Autism Immune Component
MDedge Psychiatry
Valproate Exposure Associated With Autism, Lower IQ
MDedge Psychiatry
Epilepsy Patients Take Control
MDedge Psychiatry
Cortical Demyelination, Inflammation Found in Early MS
MDedge Psychiatry
Complex Partial Seizures Bode Ill for Children's Futures
MDedge Psychiatry
Barriers to Epilepsy Care Continue to Frustrate
MDedge Psychiatry
Pediatric VNS Surgery: Pay Now or Pay More Later
MDedge Psychiatry